Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit
SEATTLE, Sept. 23, 2022 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ:NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the upcoming Capital One Spatial Biology & Proteomics Summit taking place virtually on Wednesday, September 28, 2022.
Related news for (NAUT)
- MoBot alert highlights: NYSE: MSN, NASDAQ: AIRE, NASDAQ: BYND, NASDAQ: ADVB, NASDAQ: NAUT (10/21/25 01:00 PM)
- MoBot alert highlights: NASDAQ: BYND, NASDAQ: ADVB, NASDAQ: NAUT, NASDAQ: RANI, NASDAQ: VELO (10/21/25 12:00 PM)
- Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
- Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award
- Nautilus Biotechnology Announces “First Access Challenge” Winners
